Background illustration for clinical trials search

Paid Clinical Trials Memphis

Discover 522 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 522

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

for

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Location: Memphis TN, Southhaven MS, Collierville TN,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04269902

Phase3, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for

Recurrent Lung Non-Small Cell Carcinoma,

Location: Memphis TN, Southhaven MS, Collierville TN,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase2, Phase3, Recruiting

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

for

Pancreatic Acinar Cell Carcinoma,

Location: Memphis TN, Southhaven MS, Collierville TN,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04858334

Phase2, Recruiting

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

for

Metastatic Small Intestinal Adenocarcinoma,

Location: Memphis TN, Southhaven MS, Collierville TN,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04205968

Phase2, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Location: Memphis TN, Tupelo MS, Nashville TN, Huntsville AL,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

for

Locally Advanced Lung Non-Small Cell Carcinoma,

Location: Memphis TN, Southhaven MS, Collierville TN,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05624996

Phase3, Recruiting

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

for

Aortic Stenosis, Calcific, Aortic Valve Stenosis

Location: Germantown TN, Jacksonville FL, Nashville TN,

Sponsor: Edwards Lifesciences

Sex: All

Age: 65+

Code: NCT04889872

Recruiting

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

for

Recurrent Lung Non-Small Cell Carcinoma,

Location: Memphis TN, Southhaven MS, Collierville TN,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05642572

Phase2, Recruiting

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for

Breast Carcinoma, Colorectal Carcinoma,

Location: Memphis TN, Southaven MS, Collierville TN, Jonesboro AR,

Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18+

Code: NCT06418204

Recruiting

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

for

Metastatic Colorectal Adenocarcinoma,

Location: Memphis TN, Southhaven MS, Oxford MS, New Albany MS,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05673148

Phase2, Recruiting

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

for

Hematopoietic and Lymphatic System Neoplasm,

Location: Memphis TN, Oxford MS, Rolla MO, Mount Vernon IL,

Sponsor: National Cancer Institute LAO

Sex: All

Age: 0+

Code: NCT02474160

Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for

Advanced Lung Non-Squamous Non-Small Cell Carcinoma,

Location: Memphis TN, Southhaven MS, Collierville TN,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase3, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

for

Lung Non-Small Cell Carcinoma

Location: Memphis TN, Southhaven MS, Collierville TN,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06116682

Phase2, Recruiting

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

for

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum

Location: Memphis TN, Little Rock AR, Cape Girardeau MO,

Sponsor: NRG Oncology

Sex: All

Age: 45 - 70

Code: NCT05080673

Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for

Metastatic Malignant Neoplasm in the Liver,

Location: Memphis TN, Southhaven MS, Collierville TN, Oxford MS,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for

Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),

Location: Memphis TN, Southhaven MS, Collierville TN,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

for

Myelodysplastic Syndromes, Cytopenia

Location: Memphis TN, Hot Springs AR, Houston TX, Tampa FL,

Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT04419649

Phase2, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for

Breast Cancer

Location: Oxford MS, Memphis TN, Nashville TN, St Louis MO,

Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase3, Recruiting

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

for

Lung Carcinoma

Location: Memphis TN, Jackson MS, Newnan GA, Houston TX,

Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06196008

Recruiting

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC

for

Non-small Cell Lung Cancer

Location: Memphis TN, Nashville TN, Baton Rouge LA, Pinehurst NC,

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06745882

Phase2, Recruiting

Paid Clinical Trials Memphis

Filter results

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Interested in new trials?

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC